Hi there,

Democracy Now is committed to bringing you the stories and perspectives you won't hear anywhere else, from the peace activists demanding an end to war to Indigenous leaders fighting to stop fossil fuel extraction and save the planet. Our independent reporting is only possible because we’re funded by you—not by the weapons manufacturers when we cover war or gun violence, not by the oil, gas, coal, or nuclear companies when we cover the climate crisis. Can you donate $10 today to keep us going strong? Every dollar makes a difference. Right now a generous donor will DOUBLE your donation, making it twice as valuable to Democracy Now! Please do your part today, and thank you so much.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

AIDS activists and the pharmaceutical industry

Listen
Media Options
Listen

AIDS activists with ACT UP yesterday seized the investor relations office of pharmaceutical giant Glaxo Wellcome to protest what they say is the company’s criminally inadequate AIDS drug development program and its failure to make new drugs more widely available. Police arrested seven people.

Yesterday’s action is just the latest in a growing number protests worldwide against the pharmaceutical industry. AIDS activists say that the industry charges too much money for their drugs and unnecessarily restricts access to new drugs.

Guests on the program are Jennifer McMillan, director of healthcare coalitions and advocacy relations at Glaxo Wellcome, and Bill Bahlman and Norberto Stuart, two ACT UP activists, both living with AIDS.

Take a look at the AIDS patent database at the US Patent and Trade Office and the AIDS Virtual Library.

Related Story

StoryMay 12, 20222021 Nobel Literature Prize Winner Abdulrazak Gurnah on Colonialism & the Power of Language
The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top